Schizoaffective Disorders Completed Phase 3 Trials for Lurasidone (DB08815)

Also known as: Schizoaffective disorder / Schizophrenia schizoaffective / Schizoaffective psychosis / Schizo-affective type schizophrenia

IndicationStatusPhase
DBCOND0033299 (Schizoaffective Disorders)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00641745Lurasidone HCl - A Long Term Safety Phase 3 Study of Patients With Clinically Stable SchizophreniaTreatment
NCT01143090A Study of Subjects Switched to Lurasidone for the Treatment of Schizophrenia or Schizoaffective DisorderTreatment
NCT01143077A Study Evaluating Lurasidone for The Treatment of Schizophrenia or Schizoaffective Disorder in Subjects Switched From Other Antipsychotic AgentsTreatment